Literature DB >> 4892433

Chemotherapy of leprosy.

C C Shepard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4892433     DOI: 10.1146/annurev.pa.09.040169.000345

Source DB:  PubMed          Journal:  Annu Rev Pharmacol        ISSN: 0066-4251            Impact factor:   13.820


× No keyword cloud information.
  7 in total

1.  Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats.

Authors:  J H Peters; G R Gordon; J F Murray; A H Fieldsteel; L Levy
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

2.  Structure-activity of sulfones and sulfonamides on dihydropteroate synthetase from Neisseria meingitidis.

Authors:  R I Ho; L Corman; S A Mores; H Schneider
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

3.  Some recent laboratory findings on Mycobacterium leprae. Implications for the therapy, epidemiology and control of leprosy.

Authors:  L M Bechelli; R S Guinto
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  Comparative effects of sulfones and rifampin on growth of Mycobacterium lepraemurium in macrophage diffusion chamber cultures.

Authors:  W A Rightsel; M F Sawyers; J H Peters
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

5.  Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients.

Authors:  B Ruf; D Schürmann; H Mauch; G Jautzke; F J Fehrenbach; H D Pohle
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

6.  N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.

Authors:  H Uehleke; S Tabarelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides.

Authors:  J L McCullough; T H Maren
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.